Riskpilot← Back to searchSign inGet full accessAkival AB
ABActiveOrg 5568952013Samaritgränd 6Medical specialists activities · NACE 8622Est. 20121-4 employees
Revenue 2025
SEK 4M
+29% vs 2024
EBITDA margin
18.4%
-52% vs 2024
Equity ratio
46.3%
Financial strength
Net profit 2025
SEK 104K
-82% vs 2024
| Revenue | SEK 4M | +29% |
| EBITDA | SEK 734K | -52% |
| Net profit | SEK 104K | -82% |
| Total assets | SEK 8,4M | -45% |
| Equity | SEK 3,9M | -4% |
| Employees | — | — |
Legal name
Akival AB
Org number
5568952013
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
4 juni 2012
Share capital
SEK 50 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Vårdtjänster läkartjänster Äga och förvalta fastigheter
Address
Samaritgränd 6
Email
valenthina.pavlova@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2 282 | 3 277 | 2 513 | 3 096 | 3 990 |
| Staff expenses | — | — | −1 019 | −1 419 | −1 697 |
| EBITDA | 1 025 | 1 496 | 1 247 | 1 534 | 734 |
| Depreciation & amort. | −168 | −242 | −242 | −247 | −155 |
| EBIT | 857 | 1 254 | 1 006 | 1 286 | 579 |
| Net financials | −103 | −211 | −387 | −536 | −377 |
| Profit before tax | 1 005 | 1 043 | 769 | 750 | 485 |
| Tax | −219 | −217 | −167 | −162 | −381 |
| Net profit | 786 | 826 | 602 | 588 | 104 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 15 376 | 15 564 | 15 497 | 15 229 | 8 410 |
| Equity | 3 256 | 3 682 | 3 865 | 4 054 | 3 891 |
| Long-term debt | 11 288 | 10 800 | 10 891 | 10 463 | 3 889 |
| Short-term debt | 398 | 648 | 459 | 429 | 629 |
| Total debt | 11 686 | 11 448 | 11 349 | 10 892 | 4 519 |
EBITDA margin
18.4%
This company
15.8%
Market median
+16% vs market
20212025
Equity ratio
46.3%
This company
38.2%
Market median
+21% vs market
20212025
Return on equity
2.7%
This company
18.4%
Market median
-85% vs market
20212025
Net profit margin
2.6%
This company
8.1%
Market median
-68% vs market
20212025
Asset turnover
0.47×
This company
1.12×
Market median
-58% vs market
20212025
Debt / equity
1.16×
This company
0.62×
Market median
-87% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
VL Chief Executive Officer | Chief Executive Officer | 2022 |
AA Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2024 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Akival AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Valenthina Louzz Pavlova | Chief Executive Officer | 0 companies |
| Antonio Akiki | Deputy Chief Executive Officer | 0 companies |